Swain Lenz to Speak at Large Genomic Conference
Sequencing and Genomic Technologies Director, Devjanee (Devi) Swain Lenz, will be one of the invited panel speakers at the Festival of Genomics and Biodata conference
Outsmarting Superbugs, One Germ at a Time
It’s an old story: Pathogen sickens humans. Humans create medicine. Pathogen evolves a way around the medicine. Humans are back to square one.
Blood May Hold the Key to Cheating Father Time
James White, PhD, Gurpreet Baht, PhD, and team show that biological age is fluid, and while it can age faster under stress, it can also be restored once those stressors are eliminated.
New Cause Identified for Metabolic Disease that Strikes Native Americans
Duke Health researchers have identified the cause of an inherited metabolic disease common among people with Lumbee and other Native American heritage.
New Equipment in Molecular Genomics Core
The Molecular Genomics Core in the Duke Molecular Physiology Institute (DMPI) has added a 10xGenomics in situ sequencing platform called Xenium.
The new platform allows for single cell spatial resolution of gene expression and provides spatial context of targeted RNA profiles within tissues.
Simon Gregory among those honored for breast cancer gene discovery
In December 1995, the work of over 40 researchers culminated with a landmark publication in Nature. The team had discovered a second breast cancer susceptibility gene: BRCA2. Their discovery revolutionized cancer research and screening in breast, ovarian, and prostate cancers and has impacted millions of people’s lives in the years since.
Rethinking the Use of Race and Other Labels in Genetics Research
A national committee co-chaired by Duke Professor Charmaine Royal issued a report that emphasized the high stakes of ensuring that genetics research benefits all groups in society and mitigates harm.
Study Reveals How UV Radiation May Drive Melanoma
Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.
Alumnus Ariel Kantor Cited by Forbes Europe in 30 Under 30 List
Duke alumnus, former member of the Gersbach lab, and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.
Mysterious Benefactor Leaves a Legacy to Improve Children’s Health
An $11M gift from a mysterious benefactor is being used to create a new children’s health research project, co-led by Sarah Armstrong and Chris Newgard.